# Tvardi Therapeutics, Inc.: Form 8-K, filed Apr 15, 2025

- Company: [Tvardi Therapeutics, Inc.](/companies/tvrd.md) (CIK 1346830)
- Form: 8-K
- Filed: 2025-04-15
- Accepted by EDGAR: Apr 15, 2025, 16:06 ET
- Period: 2025-04-15
- Accession: 0001104659-25-035121
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1346830/000110465925035121/tm2512159d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1346830/000110465925035121/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 3.03: Change to security holders’ rights
- Item 5.01: Change in control
- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 5.05: Item not in the standard list
- Item 5.06: Item not in the standard list
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1346830/000110465925035121/tm2512159d1_8k.htm

Filed Apr 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-035121. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.